These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25054142)

  • 41. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
    J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel oncostatin M/interleukin-31 receptor mutation in familial primary localized cutaneous amyloidosis.
    Adams R; Colmont C; Mukhtar A; Morgan H; Patel GK
    Clin Exp Dermatol; 2020 Mar; 45(2):254-256. PubMed ID: 31478212
    [No Abstract]   [Full Text] [Related]  

  • 43. Polymorphic corneal amyloidosis: a disorder due to a novel mutation in the transforming growth factor beta-induced (BIGH3) gene.
    Eifrig DE; Afshari NA; Buchanan HW; Bowling BL; Klintworth GK
    Ophthalmology; 2004 Jun; 111(6):1108-14. PubMed ID: 15177960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of common mutations in sporadic primary localized cutaneous amyloidosis by DNA mass spectrometry.
    Chang YT; Lin CH; Lee CT; Lin MW; Liu LY; Chen CC; Lee DD; Liu HN; Tsai SF; Matsuura I
    Br J Dermatol; 2014 Apr; 170(4):974-6. PubMed ID: 24237668
    [No Abstract]   [Full Text] [Related]  

  • 46. A Th2 cytokine interleukin-31 signature in a case of sporadic lichen amyloidosis.
    Dousset L; Seneschal J; Boniface K; Charreau S; Ezzedine K; Milpied B; Mossalayi MD; McGrath JA; Lecron JC; Taïeb A
    Acta Derm Venereol; 2015 Feb; 95(2):223-4. PubMed ID: 24573820
    [No Abstract]   [Full Text] [Related]  

  • 47. Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant.
    Donovan DT; Levy ML; Furst EJ; Alford BR; Wheeler T; Tschen JA; Gagel RF
    Henry Ford Hosp Med J; 1989; 37(3-4):147-50. PubMed ID: 2576950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.
    Kim MS; Louwagie J; Carvalho B; Terhaar Sive Droste JS; Park HL; Chae YK; Yamashita K; Liu J; Ostrow KL; Ling S; Guerrero-Preston R; Demokan S; Yalniz Z; Dalay N; Meijer GA; Van Criekinge W; Sidransky D
    PLoS One; 2009 Aug; 4(8):e6555. PubMed ID: 19662090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia.
    Hofstra RM; Sijmons RH; Stelwagen T; Stulp RP; Kousseff BG; Lips CJ; Steijlen PM; Van Voorst Vader PC; Buys CH
    J Invest Dermatol; 1996 Aug; 107(2):215-8. PubMed ID: 8757765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis.
    Hamidi Asl K; Liepnieks JJ; Nakamura M; Parker F; Benson MD
    Biochem Biophys Res Commun; 1999 Apr; 257(2):584-8. PubMed ID: 10198255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.
    Keulen DV; Pouwer MG; Emilsson V; Matic LP; Pieterman EJ; Hedin U; Gudnason V; Jennings LL; Holmstrøm K; Nielsen BS; Pasterkamp G; Lindeman JHN; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
    PLoS One; 2019; 14(8):e0221477. PubMed ID: 31461490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncostatin M upregulates Livin to promote keratinocyte proliferation and survival via ERK and STAT3 signalling pathways.
    Wang H; Lei L; Hu J; Li Y
    Exp Physiol; 2020 Jul; 105(7):1151-1158. PubMed ID: 32359099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties.
    Yu M; Kissling S; Freyschmidt-Paul P; Hoffmann R; Shapiro J; McElwee KJ
    Exp Dermatol; 2008 Jan; 17(1):12-9. PubMed ID: 17979974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.
    West NR; Murphy LC; Watson PH
    Endocr Relat Cancer; 2012 Apr; 19(2):181-95. PubMed ID: 22267707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiology of pruritus in primary localized cutaneous amyloidosis.
    Tey HL; Cao T; Nattkemper LA; Tan VW; Pramono ZA; Yosipovitch G
    Br J Dermatol; 2016 Jun; 174(6):1345-50. PubMed ID: 26748444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
    Hsu MP; Frausto R; Rose-John S; Campbell IL
    Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of oncostatin M receptor gene polymorphisms in bladder cancer.
    Deng S; He SY; Zhao P; Zhang P
    World J Surg Oncol; 2019 Feb; 17(1):30. PubMed ID: 30755233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of oncostatin M receptor beta in a specific subset of nociceptive sensory neurons.
    Tamura S; Morikawa Y; Miyajima A; Senba E
    Eur J Neurosci; 2003 Jun; 17(11):2287-98. PubMed ID: 12814362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology.
    Hermanns HM
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):545-58. PubMed ID: 26198770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.